An order prohibiting the sale and use of hemp flowers that have been infused with the cannabidiol (CBD), the non-psychoactive component of cannabis, has been revoked by the French Conseil D’état (State council). Customers seeking a substitute for the psychoactive cannabis component tetrahydrocannabinol (THC), which is illegal in France, frequently ingest CBD flowers in the form of joints. This represented a blessing for the 2,000 specialty stores that sell CBD and the whole supply chain that supports them affected by the current crisis. 2014 saw the beginning of legal action against Kanavape, a CBD vape marketed as “the first 100% legal hemp electronic cigarette.” which initiated a legal quid pro quo between the various government bodies in France and Europe.
An order from the government prohibiting the sale of hemp flowers containing cannabidiol, the non-psychoactive component of cannabis, was temporarily suspended in January after the sector successfully petitioned for it. In the cannabis dossier, the administration reversed course. The provision of the government decree that forbade the sale and use of flowers rich with cannabidiol (CBD), the non-psychoactive component of cannabis, was finally retracted by the Council of State on December 29, 2018. The injunction was momentarily delayed by the interim relief court in January 2022 after it was declared an emergency by industry professionals. The text’s most defining metric has been firmly buried eleven months later.
Recent market research from Weedy.fr estimated the CBD market to be potentially worth up to 1.5Bn euros per year in France behind Germany and UK which are considered the leader in the market in Europe. Nevertheless, it is still hard to accurately estimate the market as the estimation varies widely.
This may open a new segment for French and European indoor farming companies as the market opens up and gets a legal framework.
Image provided by Aphiwat chuangchoem
You must log in to post a comment.